Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations

Mammalian Genome

Volumn 17, Issue 2, 2006, Pages 119-128

  Plummer, Nicholas W ^a   Squire, Teresa L ^a   Srinivasan, Sudha ^a   Huang, Elizabeth ^a   Zawistowski, Jon S ^a   Matsunami, Hiroaki ^a   Hale, Laura P ^a   Marchuk, Douglas A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE;

ANIMAL MODEL; ARTICLE; CAVERNOUS SINUS; CELL TYPE; CENTRAL NERVOUS SYSTEM MALFORMATION; CHOROID PLEXUS; ENZYME ACTIVITY; GENE EXPRESSION; GENE INSERTION; HETEROZYGOSITY; IN SITU HYBRIDIZATION; MOUSE; NERVE CELL; NONHUMAN; VASCULAR ENDOTHELIUM;

ANIMALS; BASE SEQUENCE; BRAIN; CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS; CEREBRAL HEMORRHAGE; CHOROID PLEXUS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HETEROZYGOTE; IN SITU HYBRIDIZATION; MICE; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; NEURONS; ORGAN SPECIFICITY;

ANIMALIA;

EID: 32144445914     PISSN: 09388990     EISSN: 14321777     Source Type: Journal    
DOI: 10.1007/s00335-005-0098-8     Document Type: Article

References (34)

1. Abbott NJ (2002) Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 200, 629-638
2. Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, et al. (2005) Mutations within the Programmed Cell Death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 76, 42-51
3. Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A (1994) GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 14, 1030-1037
4. Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D (2001) Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 71, 188-192
5. Cyr M, Caron MG, Johnson GA, Laakso A (2005) Magnetic resonance imaging at microscopic resolution reveals subtle morphological changes in a mouse model of dopaminergic hyperfunction. NeuroImage 26, 83-90
6. Denier C, Gasc JM, Chapon F, Domenga V, Lescoat C, et al. (2002) Krit1/cerebral cavernous malformation 1 mRNA is preferentially expressed in neurons and epithelial cells in embryo and adult. Mech Dev 117, 363-367
7. Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, et al. (2004) Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet 74, 326-337
8. Faisst AM, Gruss P (1998) Bodenin: a novel murine gene expressed in restricted areas of the brain. Dev Dyn 212, 293-303
9. Gault J, Shenkar R, Recksiek P, Awad IA (2005) Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke 36, 872-874
10. Gunel M, Laurans MSH, Shin D, DiLuna ML, Voorhees J, et al. (2002) KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein. Proc Natl Acad Sci USA 99, 10677-10682
11. Guzeloglu-Kayisli O, Amankulor NM, Voorhees J, Luleci G, Lifton RP, et al. (2004a) KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex. Neurosurgery 54: 943-949
12. Guzeloglu-Kayisli O, Kayisli UA, Amankulor NM, Voorhees JR, Gokce O, et al. (2004b) Krev1 interaction trapped-1/cerebral cavernous malformation-1 protein expression during early angiogenesis. J Neurosurg Spine 100: 481-487
13. Hof PR (2000) Comparative Cytoarchitectonic Atlas of the C57BL/6 J and 129/Sv Mouse Brains (Amserdam, New York: Elsevier)
14. Johnson GA, Cofer GP, Fubara B, Gewalt SL, Hedlund LW, et al. (2002) Magnetic resonance histology for morphologic phenotyping. J Magn Reson Imaging 16, 423-429
15. Kehrer-Sawatzki H, Wilda M, Braun VM, Richter HP, Hameister H (2002) Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1). Acta Neuropathol 104: 231-240
16. Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, et al. (1999) Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23, 189-193
17. Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, et al. (2003) Mutations in a gene encoding a novel protein containing a phosphotyrosine- binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73, 1459-1464
18. Maronpot RR, Sills RC, Johnson GA (2004) Applications of magnetic resonance microscopy. Toxicol Pathol 2, 42-48
19. McCarty JH, Lacy-Hulbert A, Charest A, Bronson RT, Crowley D, et al. (2005) Selective ablation of alphav integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration, and premature death. Development 132: 165-176
20. Moriarity JL, Clatterbuck RE, Rigamonti D (1999) The natural history of cavernous malformations. Neurosurg Clin North Am 10, 411-417
21. Plummer NW, Gallione CJ, Srinivasan S, Zawistowski JS, Louis DN, et al. (2004) Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am J Pathol 165, 1509-1518
22. Plummer NW, Zawistowski JS, Marchuk DA (2005) Genetics of cerebral cavernous malformations. Curr Neurol Neurosci Rep 5, 391-396
23. Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, et al. (1999) Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 8, 2325-2333
24. Schaeren-Wiemers N, Gerfin-Moser A (1993) A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry 100, 431-440
25. Serini G, Bussolino F (2004) Common cues in vascular and axon guidance. Physiology 19, 348-354
26. Uhlik MT, Abell AN, Johnson NL, Sun W, Cuevas BD, et al. (2003) Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat Cell Biol 5, 1104-1110
27. Urness LD, Li DY (2004) Wiring the vascular circuitry: from growth factors to guidance cues. In: Current Topics in Developmental Biology 62, Schatten GP (ed). (New York: Academic Press), pp 87-126
28. Valverde F (1998) Golgi Atlas of the Postnatal Mouse Brain (New York: Springer Verlag)
29. Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY (2004) Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 131, 1437-1448
30. Wong JH, Awad IA, Kim JH (2000) Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery 46, 1454-1459
31. Zabramski JM, Henn JS, Coons S (1999) Pathology of cerebral vascular malformations. Neurosurg Clin North Am 10, 395-410
32. Zawistowski JS, Serebriiskii IG, Lee MF, Golemis EA, Marchuk DA (2002) KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum Mol Gen 11, 389-396
33. Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, et al. (2005) CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet 14, 2521-2531
34. Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC (2001) Interaction between krit1 and icaplalpha infers perturbation of integrin betal-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10, 2953-2960